SAN

82.86

-0.3%↓

UCB

266

+3.18%↑

SHL.DE

36.34

+0.78%↑

ARGX

639

+3.23%↑

VIE

33.29

+0.79%↑

SAN

82.86

-0.3%↓

UCB

266

+3.18%↑

SHL.DE

36.34

+0.78%↑

ARGX

639

+3.23%↑

VIE

33.29

+0.79%↑

SAN

82.86

-0.3%↓

UCB

266

+3.18%↑

SHL.DE

36.34

+0.78%↑

ARGX

639

+3.23%↑

VIE

33.29

+0.79%↑

SAN

82.86

-0.3%↓

UCB

266

+3.18%↑

SHL.DE

36.34

+0.78%↑

ARGX

639

+3.23%↑

VIE

33.29

+0.79%↑

SAN

82.86

-0.3%↓

UCB

266

+3.18%↑

SHL.DE

36.34

+0.78%↑

ARGX

639

+3.23%↑

VIE

33.29

+0.79%↑

Search

Draegerwerk AG & Co KGaA- PREF

Open

BrancheGesundheitswesen

91.2 1.11

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

90

Max

92

Schlüsselkennzahlen

By Trading Economics

Einkommen

24M

36M

Verkäufe

53M

833M

KGV

Branchendurchschnitt

10.779

57.05

Dividendenrendite

2.89

Gewinnspanne

4.282

Angestellte

16,684

EBITDA

39M

92M

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+1.33% upside

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

2.89%

2.52%

Nächstes Ergebnis

30. Apr. 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

1.3B

Vorheriger Eröffnungskurs

90.09

Vorheriger Schlusskurs

91.2

Nachrichtenstimmung

By Acuity

59%

41%

297 / 349 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Bullish Evidence

Draegerwerk AG & Co KGaA- PREF Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

31. März 2026, 23:31 UTC

Heiße Aktien

Stocks to Watch: Nike, RH, NCino

31. März 2026, 22:35 UTC

Ergebnisse

Nike Guides for Sales Declines Ahead as Turnaround Plan Hits Snags -- 2nd Update

1. Apr. 2026, 00:00 UTC

Akquisitionen, Fusionen, Übernahmen

The Year Is Off to the Strongest Start for Big Deals Ever -- WSJ

31. März 2026, 23:50 UTC

Akquisitionen, Fusionen, Übernahmen

Nxera Pharma: Partner Centessa Pharmaceuticals to Be Acquired by Lilly >LLY 4565.TO

31. März 2026, 23:43 UTC

Market Talk

Nikkei May Rise on Hopes for Iran War Ending Soon -- Market Talk

31. März 2026, 23:33 UTC

Market Talk
Wichtige Nachrichtenereignisse

Gold Edges Higher on Signs of De-Escalating Middle East Tensions -- Market Talk

31. März 2026, 23:21 UTC

Ergebnisse

Nike Stock Slides on Tariff Impact Despite Earnings Beat; Turnaround Continues -- Barrons.com

31. März 2026, 23:14 UTC

Market Talk
Ergebnisse

Nike CEO Says Turnaround is Taking Longer Than He'd Like -- Market Talk

31. März 2026, 23:12 UTC

Market Talk

Aurelia's Cash Flow Strength Highlighted by New Financing Deal -- Market Talk

31. März 2026, 22:36 UTC

Ergebnisse

China Vanke 2025 Loss Widens >000002.SZ

31. März 2026, 22:36 UTC

Ergebnisse

China Vanke: Increase in Inventory Impariment Provision Among Factors Weighing On Results>000002.SZ

31. März 2026, 22:36 UTC

Ergebnisse

China Vanke 2025 Loss CNY88.56B Vs. Loss CNY49.48B >000002.SZ

31. März 2026, 22:36 UTC

Ergebnisse

China Vanke: Will Take Time to Resolve Issues Caused by High Debt Levels>000002.SZ

31. März 2026, 22:36 UTC

Ergebnisse

China Vanke 2025 Rev CNY233.43B Vs. CNY343.18B >000002.SZ

31. März 2026, 21:46 UTC

Akquisitionen, Fusionen, Übernahmen

Big Drug Companies Hunting for Deals Are Lowering Their Sights -- WSJ

31. März 2026, 21:36 UTC

Market Talk

West African Resources's Costs Higher Than Bull Expected -- Market Talk

31. März 2026, 21:35 UTC

Ergebnisse

Nike Expects China Sales Down 20% in 4Q, CFO Says

31. März 2026, 21:35 UTC

Ergebnisse

Nike Expects Modest Growth in North America, Offset by Declines in China, Converse Brand in 4Q, CFO Says

31. März 2026, 21:35 UTC

Ergebnisse

Nike Forecasts 4Q Sales Down 2% to 4%, CFO Says

31. März 2026, 21:33 UTC

Akquisitionen, Fusionen, Übernahmen

Biotechs Are a Healthy Growth Bet Thanks to M&A and New Drugs -- Barrons.com

31. März 2026, 21:33 UTC

Ergebnisse

Nike Expects Sales Down Low-Single Digits From Now Through End of Calendar Year, CFO Says

31. März 2026, 21:32 UTC

Ergebnisse

Nike Expects 1Q to Be Final Quarter Where Tariffs Continue to Be Year-Over-Year Headwind to Margins, CFO Says

31. März 2026, 21:28 UTC

Ergebnisse

Nike Expects to End 4Q With Elevated Inventory, CFO Says

31. März 2026, 21:26 UTC

Ergebnisse

Nike Increasingly Confident It Will Return to Balanced Growth in North America in Direct, Wholesale Channels, CFO Says

31. März 2026, 21:25 UTC

Ergebnisse

Nike Expects Supply-Chain Changes to Pay Off Starting in Fiscal 2027, CFO Says

31. März 2026, 21:24 UTC

Market Talk
Ergebnisse

Nike: Turnaround Plan Progressing at Different Rates -- Market Talk

31. März 2026, 21:22 UTC

Ergebnisse

Nike CFO Expects Football Training and Basketball Will Return to Growth Over Next Few Quarters

31. März 2026, 21:22 UTC

Ergebnisse

Nike's Sportswear Business Declined Low-Double Digits in 3Q, CFO Says

31. März 2026, 21:21 UTC

Ergebnisse

Nike's Digital Channel Still Too Promotional, CFO Says

31. März 2026, 21:20 UTC

Ergebnisse

Nike CEO: Converse Remains Important to Portfolio

Peer-Vergleich

Kursveränderung

Draegerwerk AG & Co KGaA- PREF Prognose

Kursziel

By TipRanks

1.33% Vorteil

12-Monats-Prognose

Durchschnitt 91.5 EUR  1.33%

Hoch 110 EUR

Tief 73 EUR

Basierend auf 3 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Draegerwerk AG & Co KGaA- PREF – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

3 ratings

1

Buy

2

Halten

0

Sell

Technischer Score

By Trading Central

61.1 / 63.2Unterstützung & Widerstand

Kurzfristig

Bullish Evidence

Mittelfristig

Bullish Evidence

Langfristig

Bullish Evidence

Stimmung

By Acuity

297 / 349 Ranking in Gesundheitswesen

Nachrichtenstimmung

Bärische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Draegerwerk AG & Co KGaA- PREF

Drägerwerk AG & Co. KGaA operates as a medical and safety technology company worldwide. It develops, produces, and markets system solutions, equipment, and services for acute point of care, including emergency medicine, perioperative care, intensive care, and perinatal medicine. The company also develops, produces, and markets products, system solutions, and services for personal protection, gas detection technology, and integrated hazard management to customers in industry and mining sectors, as well as public sectors, such as fire departments, police, and disaster protection. Its products portfolio includes anesthesia devices and ventilators, thermoregulation equipment, hospitable consumables and accessories, supply units, lights, gas management systems, patient monitoring, software applications, system products, and other services. The company's product portfolio also comprises stationary and mobile gas detection systems, personal protective equipment, and alcohol and drug testing devices. In addition, it offers various training and services, as well as fire training facilities for firefighters. The company was founded in 1889 and is headquartered in Lübeck, Germany. Drägerwerk AG & Co. KGaA operates as a subsidiary of Stefan DrÄGer Gmbh.
help-icon Live chat